Unknown

Dataset Information

0

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.

SUBMITTER: Oran DP 

PROVIDER: S-EPMC7281624 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Oran Daniel P DP   Topol Eric J EJ  

Annals of internal medicine 20200603 5


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomat  ...[more]

Similar Datasets

| S-EPMC7810105 | biostudies-literature
| S-EPMC8403749 | biostudies-literature
| S-EPMC8965217 | biostudies-literature
| S-EPMC7304419 | biostudies-literature
| S-EPMC8905556 | biostudies-literature
| S-EPMC8013320 | biostudies-literature
| S-EPMC9863678 | biostudies-literature
| S-EPMC7763517 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-EPMC8064747 | biostudies-literature